Joaquin Duato said Johnson & Johnson has had only eight CEOs in about 130 years and that he is the first born outside the United States.
“In our 130 years of history, we have had only eight CEOs. And I am the first one who is not born in the U.S.”
Person
1 episodes · 7 quoted claims
Joaquin Duato said Johnson & Johnson has had only eight CEOs in about 130 years and that he is the first born outside the United States.
“In our 130 years of history, we have had only eight CEOs. And I am the first one who is not born in the U.S.”
Joaquin Duato was not advanced to a second interview when he first interviewed with Johnson & Johnson after graduate school, and he joined another pharmaceutical company before returning.
“when I finished graduate school, I interviewed with Johnson & Johnson, and I didn't make it to the second interview.”
Joaquin Duato said average employee tenure at Johnson & Johnson in the U.S. is more than a decade.
“Our average tenure, for example, in the U.S. is more than a decade.”
Joaquin Duato said Band-Aid, Tylenol and baby shampoo brands now sit within the separated consumer company Kenvue.
“Band-Aids, Tylenol, or baby shampoo, now they are all in Canview.”
Joaquin Duato said competing with L'Oreal in skincare while also competing in biologics and surgical robotics was too complex for Johnson & Johnson.
“For us, it was very complex to be able to compete with L 'Oreal, as you mentioned, in skincare and at the same time competing biologics with biopharmaceutical companies and in surgical robotics with medical technology companies.”
Joaquin Duato said Johnson & Johnson can work in cell therapy, robotic surgery, genetic and mRNA therapeutics and smart implants.
“We can do cell therapy, but we can do robotic surgery. We can do genetic or mRNA therapeutics, and we can do also smart implants.”
Johnson & Johnson's credo, a statement of company principles, was written 80 years before 2023, according to Joaquin Duato.
“this year is the 80th anniversary of the credo that was written”